Bicycle Therapeutics (BCYC) Interest Coverage Ratio (2021 - 2026)

Bicycle Therapeutics (BCYC) has disclosed Interest Coverage Ratio for 6 consecutive years, with 1364.21 as the latest value for Q1 2026.

  • For Q1 2026, Interest Coverage Ratio rose 0.9% year-over-year to 1364.21; the TTM value through Mar 2026 reached 1193.81, down 361.45%, while the annual FY2025 figure was 1199.34, 888.63% down from the prior year.
  • Interest Coverage Ratio hit 1364.21 in Q1 2026 for Bicycle Therapeutics, down from 433.47 in the prior quarter.
  • Across five years, Interest Coverage Ratio topped out at 30.92 in Q2 2022 and bottomed at 1934.73 in Q3 2024.
  • Average Interest Coverage Ratio over 5 years is 586.56, with a median of 62.4 recorded in 2023.
  • On a YoY basis, Interest Coverage Ratio climbed as much as 66.69% in 2025 and fell as far as 3463.33% in 2025.
  • Bicycle Therapeutics' Interest Coverage Ratio stood at 39.0 in 2022, then tumbled by 69.61% to 66.14 in 2023, then plummeted by 1867.35% to 1301.21 in 2024, then skyrocketed by 66.69% to 433.47 in 2025, then crashed by 214.72% to 1364.21 in 2026.
  • According to Business Quant data, Interest Coverage Ratio over the past three periods came in at 1364.21, 433.47, and 1489.8 for Q1 2026, Q4 2025, and Q3 2025 respectively.